![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Opioid Receptor Are Mediated by G
i2 in Neuroblastoma N2A CellsDepartment of Pharmacology, Medical School, University of Minnesota, Minneapolis, Minnesota
Activation of the opioid receptor results in short-term inhibition of intracellular cAMP levels followed by receptor desensitization and subsequent increase of cAMP above the control level (adenylyl cyclase superactivation). Using adenovirus to deliver pertussis toxin-insensitive mutants of the
-subunits of Gi/o that are expressed in neuroblastoma Neuro2A cells (G
i2, G
i3, and G
o), we examined the identities of the G proteins involved in the short- and long-term action of the
-opioid receptor (DOR). Pertussis toxin pretreatment completely abolished the ability of [D-Pen2, D-Pen5]-enkephalin (DPDPE) to inhibit forskolin-stimulated intracellular cAMP production. Expression of the C352L mutant of G
i2, and not the C351L mutants of G
i3 or G
o, rescued the short-term effect of DPDPE after pertussis toxin treatment. The ability of G
i2 in mediating DOR inhibition of adenylyl cyclase activity was also reflected in the ability of G
i2, not G
i3 or G
o, to coimmunoprecipitate with DOR. Coincidently, after long-term DPDPE treatment, pertussis toxin treatment eliminated the antagonist naloxone-induced superactivation of adenylyl cyclase activity. Again, only the C352L mutant of G
i2 restored the adenylyl cyclase superactivation after pertussis toxin treatment. More importantly, the C352L mutant of G
i2 remained associated with DOR after long-term agonist and pertussis toxin treatment whereas the wild-type G
i2 did not. These data suggest that G
i2 serves as the signaling molecule in both DOR-mediated short- and long-term regulation of adenylyl cyclase activity.
Address correspondence to: Lei Zhang, Department of Pharmacology, Medical School, University of Minnesota, 6-120 Jackson Hall, 321 Church Street SE, Minneapolis, MN 55455. E-mail: zhang247{at}umn.edu
This article has been cited by other articles:
![]() |
H. Zheng, J. Chu, Y. Qiu, H. H. Loh, and P.-Y. Law Agonist-selective signaling is determined by the receptor location within the membrane domains PNAS, July 8, 2008; 105(27): 9421 - 9426. [Abstract] [Full Text] [PDF] |
||||